These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 1885420

  • 1. Comparative activities of amoxycillin, amoxycillin/clavulanic acid and tetracycline against Chlamydia trachomatis in cell culture and in an experimental mouse pneumonitis.
    Beale AS, Faulds E, Hurn SE, Tyler J, Slocombe B.
    J Antimicrob Chemother; 1991 May; 27(5):627-38. PubMed ID: 1885420
    [Abstract] [Full Text] [Related]

  • 2. Characteristics of murine model of genital infection with Chlamydia trachomatis and effects of therapy with tetracyclines, amoxicillin-clavulanic acid, or azithromycin.
    Beale AS, Upshon PA.
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1937-43. PubMed ID: 7811001
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
    Cooper CE, Slocombe B, White AR.
    J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
    [Abstract] [Full Text] [Related]

  • 6. An open, comparative evaluation of amoxycillin and amoxycillin plus clavulanic acid ('Augmentin') in the treatment of bacterial pneumonia in children.
    Jibril HB, Ifere OA, Odumah DU.
    Curr Med Res Opin; 1989 Sep; 11(9):585-92. PubMed ID: 2612203
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of clavulanic acid, amoxicillin, and ticarcillin against Chlamydia trachomatis.
    Bowie WR.
    Antimicrob Agents Chemother; 1986 Apr; 29(4):713-5. PubMed ID: 3707116
    [Abstract] [Full Text] [Related]

  • 8. Bactericidal effects of co-amoxiclav (amoxycillin clavulanic acid) against a Legionella pneumophila pneumonia in the immunocompromised weanling rat.
    Smith GM, Abbott KH, Sutherland R.
    J Antimicrob Chemother; 1992 Oct; 30(4):525-34. PubMed ID: 1490922
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Comparative study of ofloxacin+amoxicillin-clavulanic acid versus doxycycline+amoxicillin-clavulanic acid combination in the treatment of pelvic Chlamydia trachomatis infections].
    Judlin P, Koebele A, Zaccabri A, van Walleghen E, Pavis A, Badonnel Y, Dailloux M, Landes P.
    J Gynecol Obstet Biol Reprod (Paris); 1995 Oct; 24(3):253-9. PubMed ID: 7622771
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of co-amoxiclav compared with other beta-lactams, quinolones, tetracyclines and erythromycin against an experimental Chlamydia trachomatis respiratory infection.
    Beale AS.
    J Antimicrob Chemother; 1993 Nov; 32(5):781-2. PubMed ID: 8125847
    [No Abstract] [Full Text] [Related]

  • 13. Potential effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid on human granulocyte activity: a comparative study.
    Cuffini AM, Tullio V, Paizis G, Carlone NA.
    J Antimicrob Chemother; 1996 Dec; 38(6):1013-22. PubMed ID: 9023648
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bactericidal effects of amoxycillin/clavulanic acid against intracellular Legionella pneumophila in tissue culture studies.
    Stokes DH, Wilkinson MJ, Tyler J, Slocombe B, Sutherland R.
    J Antimicrob Chemother; 1989 Apr; 23(4):547-56. PubMed ID: 2745260
    [Abstract] [Full Text] [Related]

  • 17. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
    Jacobs MR, Spangler SK, Appelbaum PC.
    J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
    [Abstract] [Full Text] [Related]

  • 18. The in-vitro susceptibility of the Bacteroides fragilis group to amoxycillin-clavulanic acid.
    Brown EM.
    J Antimicrob Chemother; 1984 Oct; 14(4):367-72. PubMed ID: 6501130
    [Abstract] [Full Text] [Related]

  • 19. A meta-analysis of the use of amoxycillin-clavulanic acid in surgical prophylaxis.
    Wilson AP, Shrimpton S, Jaderberg M.
    J Hosp Infect; 1992 Nov; 22 Suppl A():9-21. PubMed ID: 1362755
    [Abstract] [Full Text] [Related]

  • 20. Amoxycillin, amoxycillin-clavulanic acid and metronidazole in the treatment of clue cell-positive discharge. A comparative clinical and laboratory study.
    van der Meijden WI, Piot P, Loriaux SM, Stolz E.
    J Antimicrob Chemother; 1987 Nov; 20(5):735-42. PubMed ID: 3429374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.